Massachusetts Pavilion at BIO 2009

Jeffrey Quillen on Biotech Survival Strategies

The False Claims Act and The Life Sciences Industry: More to Come

Patent Portfolios in a Down Economy: Smart and Strategic Investments

What Bilski Means to Biotech: Barbara Fiacco on the Significance of This Patent Litigation

Biotech in China and the ITC: DeAnn Smith Offers Trends and Insights

Thomas Barker on Top Priorities of the New Secretary of Health and Human Services

Where is the Capital Going? Dana Gordon on Biotechnology Investing

The Economy's Impact on a University's IP Portfolio - Hathaway Pease Russell